HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
51 - 60 of 188
The Dova study is for children below 18 years with primary Immune Thrombocytopenia (ITP) who have had an insufficient response to previous treatment.
We are asking teens with autism between the ages of 16-21 who have expressed interest in learning how to drive or have received their learner's permit in the past 3 months, and their parent/primary caregiver to participate in an interview study.
Our Driving after Concussion study needs the help of both healthy and recently concussed teen partners in our research to understand how concussion affects driving behaviors in teens.
Our team at the Congenital Hyperinsulinism Center at CHOP is working on a research study to determine whether an experimental gene therapy product, DTX401, is safe and effective in people with glycogen storage disease type Ia (GSDIa)
This research study uses an online survey to gather information on eating, health, and weight management in autistic youth who are overweight or obese.
ECHO is a nationwide research program whose mission is to improve the health of children for generations to come.
A gene in stem cells will then be edited to help the stem cells make more fetal hemoglobin. Higher levels of fetal hemoglobin can improve red blood cell sickling.
Evaluate the safety and efficacy of an investigational drug called "Elamipretide" in adult patients with mitochondrial disease.
The purpose of this research study is to test how people with cystic fibrosis process sugar and learn more about their risk of developing cystic fibrosis-related diabetes.